Skip to content
OpenCapital
Get started

VolitionRX Limited VNRX Q2 2025 earnings

Reported August 14, 2025 · After market close

Revenue$406.7KMiss by $474.3K
EPS-$0.06Miss by $0.01
Revenue estimate$881.0K
EPS estimate-$0.05

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$442.0K
EPS estimate-$0.70

Versus estimates

Revenue

Q1 2026$985.1KMiss by $534.2KQ4 2025$420.0KMiss by $333.6KQ3 2025$627.3KMiss by $86.8K
Q2 2025$406.7KMiss by $474.3K
Q1 2025$246.4KMiss by $837.6KQ4 2024$191.7KMiss by $353.7K

Diluted EPS

Q1 2026-$0.97Miss by $0.27Q4 2025-$0.05Miss by $0.01Q3 2025-$0.04In line
Q2 2025-$0.06Miss by $0.01
Q1 2025-$0.06In lineQ4 2024-$0.06In line

Ask the moment VolitionRX Limited reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did VolitionRX Limited report Q2 2025 earnings?
VolitionRX Limited (VNRX) reported Q2 2025 earnings on August 14, 2025 after market close.
What were VolitionRX Limited's Q2 2025 revenue and EPS?
VolitionRX Limited reported revenue of $406.7K and eps of $-0.06 for Q2 2025.
Did VolitionRX Limited beat estimates in Q2 2025?
Revenue missed the consensus estimate of $881.0K by $474.3K. EPS missed the consensus estimate of $-0.05 by $0.01.
How did VolitionRX Limited's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.8% from $395.8K a year earlier and eps grew 25.0% from $-0.08.
Where can I find VolitionRX Limited's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001477932-25-005923) directly on SEC EDGAR. The filing index links above go to sec.gov.